Skip to main content
main-content
Erschienen in: Calcified Tissue International 6/2012

01.12.2012 | Original Research

Dose-Dependent Short-Term Effects of Single High Doses of Oral Vitamin D3 on Bone Turnover Markers

verfasst von: Maurizio Rossini, Silvano Adami, Ombretta Viapiana, Elena Fracassi, Luca Idolazzi, Maria Rosaria Povino, Davide Gatti

Erschienen in: Calcified Tissue International | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

We investigated the short-term effects on bone turnover markers of high doses of vitamin D3 in order to identify what initial therapeutic dose can be safely administered in vitamin D-deficient subjects. Thirty-seven elderly subjects [mean age 75 ± 3 (SD) years] were consecutively randomized to the administration of a single oral bolus of 600000, 300000, or 100000 IU vitamin D3. Blood samples were taken at baseline and 1, 3, 7, 14, 30, 60, and 90 days after vitamin D3 administration. Twenty-four subjects served as controls. No relevant changes in bone turnover markers [C-terminal telopeptides of type I collagen (sCTX) and bone-specific alkaline phosphatase (BAP)] were observed in the controls. In treated patients a dose-dependent effect on sCTX was observed. With the administration of 600,000 IU vitamin D3 a significant increase of sCTX was observed already at day 1, and it was sustained for 2 months. The changes in sCTX with smaller doses were considerably lower and reached statistical significance only within the first 3 days with the 300,000 IU dose. BAP remained unchanged in patients given 300,000 and 600,000 IU vitamin D3, while it significantly rose by 15–23 % throughout the observation period in patients given 100,000 IU. Our results indicate that the use of a vitamin D bolus exceeding 100,000 IU may be associated with acute increases of sCTX.
Literatur
1.
Zurück zum Zitat Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373 PubMedCrossRef Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373 PubMedCrossRef
2.
Zurück zum Zitat Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501 PubMedCrossRef Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501 PubMedCrossRef
3.
Zurück zum Zitat Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930 PubMedCrossRef Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930 PubMedCrossRef
4.
Zurück zum Zitat Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC Institute of Medicine (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC
5.
Zurück zum Zitat Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E, Carnevale V, Scillitani A, Minisola S (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D 2) or vitamin D 3 (vitamin D 3) in the elderly. J Clin Endocrinol Metab 93:3015–3020 PubMedCrossRef Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E, Carnevale V, Scillitani A, Minisola S (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D 2) or vitamin D 3 (vitamin D 3) in the elderly. J Clin Endocrinol Metab 93:3015–3020 PubMedCrossRef
6.
Zurück zum Zitat Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR (2009) High-dose oral vitamin D 3 supplementation in the elderly. Osteoporos Int 20:1407–1415 PubMedCrossRef Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR (2009) High-dose oral vitamin D 3 supplementation in the elderly. Osteoporos Int 20:1407–1415 PubMedCrossRef
7.
Zurück zum Zitat Bischoff-Ferrari HA (2007) How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18:401–407 PubMedCrossRef Bischoff-Ferrari HA (2007) How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18:401–407 PubMedCrossRef
8.
Zurück zum Zitat Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D 3 (vitamin D 3) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469–475 PubMedCrossRef Trivedi DP, Doll R, Khaw KT (2003) Effect of four monthly oral vitamin D 3 (vitamin D 3) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469–475 PubMedCrossRef
9.
Zurück zum Zitat Heikinheimo R, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Kokko AM, Kolho LA, Rajala SA (1992) Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105–110 PubMedCrossRef Heikinheimo R, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Kokko AM, Kolho LA, Rajala SA (1992) Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105–110 PubMedCrossRef
10.
Zurück zum Zitat Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial. JAMA 303:1815–1822 PubMedCrossRef Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial. JAMA 303:1815–1822 PubMedCrossRef
11.
Zurück zum Zitat Rossini M, Gatti D, Viapiana O, Fracassi E, Idolazzi L, Zanoni S, Adami S (2012) Short-term effects on bone turnover markers of a single high dose of oral vitamin D 3. J Clin Endocrinol Metab 97:E622–E626 PubMedCrossRef Rossini M, Gatti D, Viapiana O, Fracassi E, Idolazzi L, Zanoni S, Adami S (2012) Short-term effects on bone turnover markers of a single high dose of oral vitamin D 3. J Clin Endocrinol Metab 97:E622–E626 PubMedCrossRef
12.
Zurück zum Zitat Wu F, Staykova T, Horne A, Horne A, Clearwater J, Ames R, Mason B, Orr-Walker B, Gamble G, Scott M, Reid I (2003) Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116:U536 PubMed Wu F, Staykova T, Horne A, Horne A, Clearwater J, Ames R, Mason B, Orr-Walker B, Gamble G, Scott M, Reid I (2003) Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116:U536 PubMed
13.
Zurück zum Zitat Hekkarinen T, Valimaki VV, Aaarum S, Turpeinen U, Hamalainen E, Loyttyniemi E, Valimaki MJ (2010) The same annual dose of 292000 IU of vitamin D 3 (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D 3 concentrations and renal function. Clin Endocrinol 72:455–461 CrossRef Hekkarinen T, Valimaki VV, Aaarum S, Turpeinen U, Hamalainen E, Loyttyniemi E, Valimaki MJ (2010) The same annual dose of 292000 IU of vitamin D 3 (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D 3 concentrations and renal function. Clin Endocrinol 72:455–461 CrossRef
14.
Zurück zum Zitat Giusti A, Barone A, Pioli G, Girasole G, Razzamo M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G (2010) Heterogeneity in serum 25-hydroxy-vitamin D response to vitamin D 3 in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 58:1489–1495 PubMedCrossRef Giusti A, Barone A, Pioli G, Girasole G, Razzamo M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G (2010) Heterogeneity in serum 25-hydroxy-vitamin D response to vitamin D 3 in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 58:1489–1495 PubMedCrossRef
15.
Zurück zum Zitat Plum LA, DeLuca HF (2009) The functional metabolism and molecular biology of vitamin D action. Clin Rev Bone Miner Metab 7:20–41 CrossRef Plum LA, DeLuca HF (2009) The functional metabolism and molecular biology of vitamin D action. Clin Rev Bone Miner Metab 7:20–41 CrossRef
16.
Zurück zum Zitat Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11:905–913 PubMedCrossRef Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11:905–913 PubMedCrossRef
17.
Zurück zum Zitat Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM (1990) DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D 3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D 3. Proc Natl Acad Sci USA 87:369–373 PubMedCrossRef Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM (1990) DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D 3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D 3. Proc Natl Acad Sci USA 87:369–373 PubMedCrossRef
Metadaten
Titel
Dose-Dependent Short-Term Effects of Single High Doses of Oral Vitamin D3 on Bone Turnover Markers
verfasst von
Maurizio Rossini
Silvano Adami
Ombretta Viapiana
Elena Fracassi
Luca Idolazzi
Maria Rosaria Povino
Davide Gatti
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 6/2012
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-012-9637-y

Weitere Artikel der Ausgabe 6/2012

Calcified Tissue International 6/2012 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.